ロード中...
A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer
The immunohistochemical determination of HER-2 to identify patients with advanced breast cancer candidates for Trastuzumab treatment proved neither accurate nor fully reliable, possibly because none of the current reagents detects the specific antigenic site target of Trastuzumab. To circumvent this...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2005
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361978/ https://ncbi.nlm.nih.gov/pubmed/15812476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602507 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|